GAMCO Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Sell |
8,000
-290
| -3% | -$15.9K | ﹤0.01% | 847 |
|
|
2025
Q1 | $586K | Sell |
8,290
-1,750
| -17% | -$124K | 0.01% | 650 |
|
|
2024
Q4 | $660K | Buy |
10,040
+3,475
| +53% | +$228K | 0.01% | 651 |
|
|
2024
Q3 | $461K | Buy |
6,565
+1,250
| +24% | +$87.9K | ﹤0.01% | 706 |
|
|
2024
Q2 | $438K | Buy |
+5,315
| New | +$438K | ﹤0.01% | 710 |
|
|
2024
Q1 | – | Sell |
-2,483
| Closed | -$239K | – | 861 |
|
|
2023
Q4 | $239K | Sell |
2,483
-231
| -9% | -$22.3K | ﹤0.01% | 781 |
|
|
2023
Q3 | $240K | Sell |
2,714
-470
| -15% | -$41.6K | ﹤0.01% | 779 |
|
|
2023
Q2 | $276K | Sell |
3,184
-360
| -10% | -$31.2K | ﹤0.01% | 768 |
|
|
2023
Q1 | $345K | Buy |
3,544
+290
| +9% | +$28.2K | ﹤0.01% | 739 |
|
|
2022
Q4 | $337K | Sell |
3,254
-243
| -7% | -$25.1K | ﹤0.01% | 748 |
|
|
2022
Q3 | $296K | Buy |
3,497
+95
| +3% | +$8.04K | ﹤0.01% | 755 |
|
|
2022
Q2 | $282K | Sell |
3,402
-660
| -16% | -$54.7K | ﹤0.01% | 783 |
|
|
2022
Q1 | $313K | Sell |
4,062
-703
| -15% | -$54.2K | ﹤0.01% | 802 |
|
|
2021
Q4 | $421K | Sell |
4,765
-5,653
| -54% | -$499K | ﹤0.01% | 766 |
|
|
2021
Q3 | $805K | Sell |
10,418
-386
| -4% | -$29.8K | 0.01% | 666 |
|
|
2021
Q2 | $901K | Buy |
10,804
+30
| +0.3% | +$2.5K | 0.01% | 661 |
|
|
2021
Q1 | $814K | Buy |
10,774
+6,504
| +152% | +$491K | 0.01% | 661 |
|
|
2020
Q4 | $374K | Buy |
+4,270
| New | +$374K | ﹤0.01% | 769 |
|
|
2019
Q2 | – | Sell |
-2,300
| Closed | -$204K | – | 930 |
|
|
2019
Q1 | $204K | Buy |
+2,300
| New | +$204K | ﹤0.01% | 810 |
|
|
2018
Q4 | – | Sell |
-2,300
| Closed | -$223K | – | 800 |
|
|
2018
Q3 | $223K | Hold |
2,300
| – | – | ﹤0.01% | 792 |
|
|
2018
Q2 | $217K | Sell |
2,300
-300
| -12% | -$28.3K | ﹤0.01% | 809 |
|
|
2018
Q1 | $211K | Hold |
2,600
| – | – | ﹤0.01% | 792 |
|
|
2017
Q4 | $232K | Buy |
+2,600
| New | +$232K | ﹤0.01% | 785 |
|